Consumer Products
Health And Wellness
Biotechnology

PolarityTE

$12.27
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.97 (-7.33%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell PolarityTE and other stocks, options, ETFs, and crypto commission-free!

About

PolarityTE, Inc. Common Stock, also called PolarityTE, is a commercial-stage biotechnology and regenerative biomaterials company, which focuses on discovering, designing and developing regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. Read More Its products include SkinTE, OsteoTE and Real Time Assistant. The company was founded on May 8, 1998 and is headquartered in Salt Lake City, UT.

Employees
123
Headquarters
Salt Lake City, Utah
Founded
1998
Market Cap
262.87M
Price-Earnings Ratio
Dividend Yield
Average Volume
526.33K
High Today
$13.12
Low Today
$12.03
Open Price
$13.00
Volume
193.60K
52 Week High
$41.22
52 Week Low
$11.54

Collections

Consumer Products
Health And Wellness
Biotechnology
Medical
Engineering
Retail
Health
US

News

Simply Wall StMar 21

PolarityTE, Inc. (NASDAQ:PTE): Will The Growth Last?

PolarityTE, Inc.’s (NASDAQ:PTE) most recent earnings update in December 2018 indicated that losses became smaller relative to the prior year’s level as a result of recent tailwinds Today I want to provide a brief commentary on how market analysts predict PolarityTE’s earnings growth trajectory over the next couple of years and whether the future looks brighter. I will be using net income excluding extraordinary items in order to exclude one-off volatility which I am not interested in. View our latest analy...

112
PR NewswireMar 21

PolarityTE Hosts Symposium Featuring SkinTE-Treated Burn Survivor, New Clinical Data at American Burn Association Annual Meeting

SALT LAKE CITY, March 21, 2019 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced today it will host a symposium at the American Burn Association (ABA) 51st Annual Meeting featuring a burn survivor who will share her story after being treated with the Company's SkinTE™ product. Additionally, two abstracts on the clinical use of SkinTE will be presented during the conference. The ABA Annual Meeting w...

3
Seeking AlphaMar 21

Evercore likes PolarityTE in premarket analyst action

Aerie Pharmaceuticals (NASDAQ:AERI) initiated with Overweight rating and $80 (74% upside) price target at Piper Jaffray. PolarityTE (NASDAQ:PTE) initiated with Outperform rating and $26 (117% upside) price target at Evercore ISI. Shares up 9% premarket. Diplomat Pharmacy (NYSE:DPLO) upgraded to Outperform with an $8 (37% upside) price target at Raymond James....

28

Earnings

-$2.13
-$1.62
-$1.11
-$0.60
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$1.04 per share
Actual
-$1.47 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.